featured
Association of Post-Operative Carcinoembryonic Antigen With Survival and Oxaliplatin Benefit in Patients With Stage 2 Colon Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of Post-Operative CEA With Survival and Oxaliplatin Benefit in Patients With Stage II Colon Cancer: A Post Hoc Analysis of the MOSAIC Trial
Br. J. Cancer 2019 Jul 12;[EPub Ahead of Print], E Auclin, T André, J Taieb, M Banzi, JL Van Laethem, J Tabernero, T Hickish, A de Gramont, D VernereyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.